Tango Therapeutics (NASDAQ:TNGX – Get Free Report) and Grifols (NASDAQ:GRFS – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, analyst recommendations, earnings and risk. Profitability This table compares Tango Therapeutics and Grifols’ net […]
Head to Head Survey: Context Therapeutics (NASDAQ:CNTX) & Grifols (NASDAQ:GRFS) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Grifols (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a global leader in the development of plasma-derived therapies and innovative diagnostic solutions, today announced it will provide the Korean Red Cross (KRC) with its industry-leading Procleix Panther System running nucleic acid testing (NAT) technology to help ensure the safety of South Korea's blood supply.